Julie Cosgrove

Head of Strategy & Operations US Market Access Sanofi

Commercial leader focused on building and scaling specialty and rare disease brands by connecting marketing, Market Access, and patient strategy. Over the past 20+ years, I've led launches, built high-performing teams, and driven growth across global and US roles in biotech and large pharma. My experience spans immunology, neurology, oncology, transplant, and metabolic disease, with deep expertise in HCP engagement, patient strategy, and omnichannel execution. What differentiates my approach is the ability to operate across the full commercial ecosystem, aligning brand strategy, access, and field execution to deliver measurable results. Most recently, I've led strategy and operations for US Market Access, driving organizational transformation and building scalable capabilities to improve performance and decision-making. I'm energized by high-growth environments and the opportunity to help companies successfully bring new therapies to market. I'm particularly interested in roles where I can lead commercial strategy and execution for launch or near-launch assets.

Pharma Launch Excellence Summit Conference Day 1: Wednesday September 30

2:30 PM Roundtable Discussion Groups

Small groups. No slides. No spectators.

Each table is built around a problem teams are actively trying to solve:

• Fixing weak uptake in the first 90 days post-launch

• Getting Medical, Access and Commercial aligned before approval

• What to cut when launch budgets tighten

• Where AI is actually saving time in launch execution

• Dealing with payer pushback on high-cost therapies

You'll leave with:

• How others are approaching it

• What's working vs failing

• Practical ideas you can take straight back

Rountables Include:

AI in Launch: Turning Experimentation into Measurable Impact
Access, Pricing and Affordability as Launch Strategy]
Medical Affairs, Evidence and Scientific Engagement Before Launch
Turning Launch Strategy into Launch Performance
Field Execution, Commercial Ops and Launch Infrastructure

Pharma Launch Excellence Summit Conference Day 2: Thursday October 1

9:00 AM Morning Presentation / Case Study: From Search to Start: How AI-Informed Patients Are Reshaping Launch

Patients are no longer only arriving at treatment conversations informed by websites, adverts or advocacy groups. Increasingly, they are using AI search, symptom tools, social content and digital health platforms to understand conditions, compare treatments and shape the questions they bring to HCPs. For launch teams, this changes the dynamics of demand generation, education, access and adherence, especially in high-cost, specialty and consumer-visible categories.

Drawing on Julie's experience across US Market Access, specialty pharma, sales, marketing, advocacy and enterprise strategy, this session will explore how AI-influenced patient behavior is reshaping launch planning, and why access, medical, commercial and patient engagement teams need to respond together.

• Understanding how AI is changing patient awareness, expectations and decision-making

• Connecting patient demand, HCP engagement and access strategy earlier

• Managing affordability and reimbursement friction as patient interest grows

• Building launch plans that account for consumer empowerment and misinformation risk

Check out the incredible speaker line-up to see who will be joining Julie.

Download The Latest Agenda

In Partnership With:

QUESTIONS?

Address: IQPC Ltd, 129 Wilton Road,
London SW1V 1JZ
Telephone: 44 (0) 207 368 9300
Fax: 44 (0) 207 368 9301
Email: enquire@iqpc.co.uk